Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 775

Showing 51-75 of 775 citing articles:

The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Santiago Cadena-Ullauri, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3585-3585
Open Access | Times Cited: 27
Role of Brain Liver X Receptor in Parkinson’s Disease: Hidden Treasure and Emerging Opportunities
Saud A. Alnaaim, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 341-357
Open Access | Times Cited: 27
Neuroinflammation in Parkinson’s Disease: From Gene to Clinic: A Systematic Review
Carlos Castillo-Rangel, Gonzalo Núñez Marín, Karla Aketzalli Hernández-Contreras, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5792-5792
Open Access | Times Cited: 26
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 26
Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease
Ping Chen, Xiaofei Geng
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 26
PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
Frida Lind‐Holm Mogensen, Andrea Scafidi, Aurélie Poli, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 24
The association between Parkinson’s disease and autoimmune diseases: A systematic review and meta-analysis
Mingqiang Li, Juan Wan, Zhenhong Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment
Hussaini Adam, Subash C. B. Gopinath, M. K. Md Arshad, et al.
3 Biotech (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 23
Biomolecule-protected gold nanoclusters: synthesis and biomedical applications
Dongzhao Hao, Xuelin Zhang, Rongxin Su, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 23, pp. 5051-5070
Closed Access | Times Cited: 23
Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach
Jiaming Liu, Xinhuang Lv, Tao Ye, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 270-282
Open Access | Times Cited: 14
The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle
Yu Cai, Yin Zhang, Shuo Leng, et al.
Neurobiology of Disease (2024) Vol. 192, pp. 106426-106426
Open Access | Times Cited: 14
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update
Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 5, pp. 899-912
Open Access | Times Cited: 13
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
Alexander Hull, Magda L. Atilano, Laith Gergi, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 12
A leaky gut dysregulates gene networks in the brain associated with immune activation, oxidative stress, and myelination in a mouse model of colitis
Jake Boles, Maeve E. Krueger, Janna Jernigan, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 473-492
Open Access | Times Cited: 11
Targeting modulation of intestinal flora through oral route by an antimicrobial nucleic acid-loaded exosome-like nanovesicles to improve Parkinson’s disease
Weitong Cui, Zhiyong Guo, Xingyu Chen, et al.
Science Bulletin (2024)
Closed Access | Times Cited: 11
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 10
Neuroinflammaging: A Tight Line Between Normal Aging and Age-Related Neurodegenerative Disorders
Luca Soraci, Andrea Corsonello, Ersilia Paparazzo, et al.
Aging and Disease (2024)
Open Access | Times Cited: 10
The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson’s disease
Fangyi Li, Guomei Weng, Hang Zhou, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 10
Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease
Meritxell Pons‐Espinal, Lucas Blasco-Agell, Irene Fernández‐Carasa, et al.
JCI Insight (2024) Vol. 9, Iss. 3
Open Access | Times Cited: 10
The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A review
Samira Hassani, Abolghasem Esmaeili
Ageing Research Reviews (2024) Vol. 97, pp. 102299-102299
Closed Access | Times Cited: 10
Microglia-derived extracellular vesicles trigger age-related neurodegeneration upon DNA damage
Ermioni S. Arvanitaki, Evi Goulielmaki, Katerina Gkirtzimanaki, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 17
Closed Access | Times Cited: 10
Artificial intelligence in Parkinson's disease: Early detection and diagnostic advancements
Aananya Reddy, Ruhananhad P. Reddy, Aryan Kia Roghani, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102410-102410
Closed Access | Times Cited: 10
Trends and hotspots in non-motor symptoms of Parkinson’s disease: a 10-year bibliometric analysis
Xuefeng Li, Chunhai Chen, Ting Pan, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 9
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
B Whittle, Osagie Izuogu, Hannah Lowes, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson’s disease
Pusheng Quan, Xueying Li, Yao Si, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9

Scroll to top